Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation

Tissue Antigens

Volumn 47, Issue 1, 1996, Pages 27-36

  Mickelson, E M ^a,b   Longton, G ^b   Anasetti, C ^a,b   Petersdorf, E ^a,b   Martin, P ^a,b   Guthrie, L A ^b   Hansen, J A ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

HLA DRB1 matching; Marrow transplantation; Mixed lymphocyte culture; Unrelated donors

Indexed keywords

HLA ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DONOR; FEMALE; GENOTYPE; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HLA MATCHING; HLA TYPING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIXED LYMPHOCYTE CULTURE; OLIGONUCLEOTIDE PROBE; PHENOTYPE; PRIORITY JOURNAL; SEROLOGY;

EID: 0030025513     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02511.x     Document Type: Article

References (50)

1. Bach FH, Hirschhorn K. Lymphocyte interaction: a potential histocompatibility test in vitro. Science 1964: 143: 813-14.
2. Rodey GE, Bortin MM, Bach FH, Rimm AA. Mixed leukocyte culture reactivity and chronic graft versus host reactions (secondary disease) between allogeneic H-2k mouse strains. Transplantation 1974: 17: 84-88.
3. Dupont B, Hansen J, Yunis EJ. Human mixed-lymphocyte culture reaction: genetics, specificity, and biological implications. Adv Immunol 1976: 23: 107-202.
4. Dupont B. Immunologic aspects of the human mixed lymphocyte culture reaction. Copenhagen: Forlaget GMT, 1978.
5. Hansen JA, Mickelson EM, Choo SY et al. Clinical bone marrow transplantation: donor selection and recipient monitoring. In: Rose NR, DeMacario EC, Fahey JL, Friedman H, Penn GM, ed. Manual of clinical laboratory immunology. Washington. DC: Am Soc Microbiol, 1992: 850-66.
6. Termijtelen A, Erlich HA, Braun LA et al. Oligonucleotide typing is a perfect tool to identify antigens stimulatory in the mixed lymphocyte culture. Hum Immunol 1991: 31: 241-5.
7. Baxter-Lowe LA, Eckels DD, Ash R et al. The predictive value of HLA-DR oligotyping for MLC responses. Transplantation 1992: 53: 1352-7.
8. Awdeh ZL, Alper CA, Fici D, Eynm E, Bishara A, Yunis EJ. Predictability of alloreactivity among unrelated individuals. Tissue Antigens 1992: 39: 51-57.
9. Thorsby E, Piazza A. Joint report from the sixth international histocompatibility workshop conference. II. Typing for HLA-D (LD-1 or MLC) determinants. In: Kissmeyer-Nielsen F, ed. Histocompatibility testing 1975. Copenhagen: Munksgaard, 1980: 414-58.
10. Mickelson EM, Anasetti C, Choo SY et al. Role of the mixed lymphocyte culture reaction (MLC) in predicting acute graft-versus-host disease (GVHD) after marrow transplants from haploidentical and unrelated donors. Transplant Proc 1993: 25: 1239-40.
11. Mickelson EM, Guthrie LA, Etzioni R, Anasetti C, Martin PJ, Hansen JA. Role of the mixed lymphocyte culture reaction in donor matching for marrow transplantation from related haploidentical donors. Tissue Antigens 1994: 44: 83-92.
12. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992: 39: 225-35.
13. Petersdorf EW, Smith AG, Mickelson EM, Martin PJ, Hansen JA. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics 1991: 33: 267-75.
14. Ng J, Hurley CK, Baxter-Lowe LA et al. Large scale oligonucleotide typing for HLA-DRB1/3/4 and HLA-DQB1 is highly accurate, specific and reliable. Tissue Antigens 1993: 42: 473-479.
15. Transplant center manual of operations. National Marrow Donor Program, 1992.
16. Hopkins KA. Basic microlymphocytotoxicity test. In: Zachary AA, Teresi GA, ed. ASHI laboratory manual. Am Soc Histocompatibility Immunogenetics, 1990: 195-201.
17. Danilovs JA, Ayoub G, Terasaki PI. Joint report: B lymphocyte isolation by thrombin-nylon wool. In: Terasaki PI, ed. Histocompatibility testing 1980. Los Angeles: UCLA Press, 1980: 287-8.
18. van Leeuwen A. Two color fluorescence. In: Zachary AA, Teresi GA, ed. ASHI laboratory manual. Am Soc Histocompatibility Immunogenetics, 1990: 201-5.
19. Mickelson E, Hansen JA. The mixed lymphocyte culture (MLC) test. In: Zachary AA, Teresi GA, ed. ASHI laboratory manual. Am Soc Histocompatibility Immunogenetics, 1990: 339-56.
20. Reinsmoen NL, Mickelson EM. HLA-Dw typing. In: Zachary AA, Teresi GA, ed. ASHI laboratory manual. Am Soc Histocompatibility Immunogenetics, 1990: 357-71.
21. Ryder LP, Thomsen M, Platz P, Svejgaard A. Data reduction in LD-typing. In: Kissmeyer-Nielsen F, ed. Histocompatibility testing 1975. Copenhagen: Munksgaard, 1975: 557-62.
22. Dupont B, Braun DW Jr, Yunis EJ, Carpenter CB. HLA-D by cellular typing. In: Terasaki PI, ed. Histocompatibility testing 1980. Copenhagen: Munksgaard, 1980: 229-67.
23. Petersdorf EW, Smith AG, Mickelson EM et al. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics 1991: 33: 267-75.
24. Mickelson EM, Smith A, McKinney S, Anderson G, Hansen JA. HLA-DRB1 typing by standard serology and sequence-specific oligonucleotide probe hybridization: a comparative study. Tissue Antigens 1993: 41: 86-93.
25. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986: 314: 729-35.
26. Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation. N Engl J Med 1975: 292: 832-43, 895-902.
27. Agresti A. Categorical data analysis. New York: John Wiley & Sons, 1990: 261-69.
28. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons, 1980.
29. Bach ML, Bach FH, Joo P. Leukemia-associated antigens in the mixed leukocyte culture test. Science 1969: 166: 1520-2.
30. Fridman WH, Kourilsky FM. Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia. Nature 1969: 224: 277-8.
31. Halterman RH, Leventhal BG. Mixed leukocyte culture (MLC) reactivity to leukemia cells in patients, their twins and HL-A identical siblings. Proc Am Assoc Cancer Res 1972: 13: 6.
32. Gutterman JU, Rossen RD, Butler WT et al. Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. N Engl J Med 1973: 288: 169-73.
33. Fefer A, Mickelson E, Thomas ED. Leukemia antigens: stimulation of lymphocytes in mixed culture by cells from HL-A identical siblings. Clin Exp Immunol 1976: 23: 214-18.
34. Kozak RW, Moody CE, Staiano-Coico L, Weksler ME. Lymphocyte transformation induced by autologous cells. XII. Quantitative and qualitative differences between human autologous and allogeneic reactive T lymphocytes. J Immunol 1982: 128: 1723-27.
35. DeGast GC, Mickelson EM, Beatty PG et al. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. Bone Marrow Transplant 1992: 9: 87-90.
36. Hansen JA, Clift RA, Thomas ED et al. Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 1980: 303: 565-67.
37. Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985: 313: 765-71.
38. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989: 320: 197-204.
39. Anasetti C, Beatty PG, Storb R et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990: 29: 79-91.
40. Mickelson EM, Hansen JA. HLA matching in marrow transplantation. Marrow Transplant Rev 1991: 1: 8-12.
41. Hansen JA, Anasetti C, Petersdorf EW et al. Status of clinical marrow transplantation and current issues in donor matching. In: Tsuji K, Aizawa M, Sasazuki T, ed. Histocompatibility testing 1991, Vol. 2. Oxford: Oxford University Press, 1992: 13-19.
42. Beatty PG, Hansen JA, Longton G et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991: 51: 443-7.
43. Beatty PG, Anasetti C, Longton G et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993: 81: 249-53.
44. Petersdorf EW, Longton GM, Anasetti C et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A. B. DR identical unrelated donor marrow transplantation. Blood (in press).
45. Amos DB, Bach FH. Phenotypic expression of the major histocompatibility locus in man (HLA-A). Leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med 1968: 128: 623-37.
46. Yunis EJ, Amos DB. Three closely linked genetic systems relevant to transplantation. Proc Natl Acad Sci U S A 1971: 68: 3031-35.
47. Mickelson E, Bartsch GE, Hansen JA, Dupont B. The MLC assay as a test for HLA-D region compatibility between patients and unrelated donors: results of a National Marrow Donor Program involving multiple centers. Tissue Antigens 1993: 42: 465-72.
48. Schroeijers WEM, de Koster HS, van Rood JJ, Termijtelen. HLA-DRbIII and HLA-DP induce comparable proliferation in primary mixed lymphocyte culture. Tissue Antigens 1988: 32: 145-49.
49. Al-Daccak R, Loiseau P, Miramont P, Rabian C, Raffoux C, Colombani J. Evaluation of HLA-Class II identity between unrelated individuals by serological typing. DNA-RFLP method, and mixed lymphocyte reaction. Hum Immunol 1990: 29: 189-201.
50. Petersdorf EW, Smith AG, Mickelson E et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993: 81: 1923-32.